LEADER 02207nam 2200625Ia 450 001 9910782038003321 005 20230721032357.0 010 $a1-282-15298-X 010 $a9786612152986 010 $a90-272-9234-5 035 $a(CKB)1000000000523053 035 $a(OCoLC)191930979 035 $a(CaPaEBR)ebrary10179980 035 $a(SSID)ssj0000128857 035 $a(PQKBManifestationID)11150074 035 $a(PQKBTitleCode)TC0000128857 035 $a(PQKBWorkID)10070215 035 $a(PQKB)11632855 035 $a(MiAaPQ)EBC622345 035 $a(Au-PeEL)EBL622345 035 $a(CaPaEBR)ebr10179980 035 $a(CaONFJC)MIL215298 035 $a(OCoLC)237626116 035 $a(EXLCZ)991000000000523053 100 $a20070323d2007 uy 0 101 0 $aeng 135 $aurcn||||||||| 181 $ctxt 182 $cc 183 $acr 200 10$aConnectives in the history of English$b[electronic resource] $e[selected papers from 13th ICEHL, Vienna, 23-28 August 2004] /$fedited by Ursula Lenker 210 $aAmsterdam ;$aPhiladelphia $cJohn Benjamins Pub.$d2007 215 $a1 online resource (328 p.) 225 0 $aAmsterdam studies in the theory and history of linguistic science. Series IV, Current issues in linguistic theory,$x0304-0763 ;$vv.283 300 $aBibliographic Level Mode of Issuance: Monograph 311 $a90-272-4798-6 320 $aIncludes bibliographical references and index. 606 $aEnglish language$xHistory$vCongresses 606 $aEnglish language$xGrammar$vCongresses 606 $aEnglish language$xConnectives$vCongresses 606 $aEnglish language$xGrammar, Historical$vCongresses 615 0$aEnglish language$xHistory 615 0$aEnglish language$xGrammar 615 0$aEnglish language$xConnectives 615 0$aEnglish language$xGrammar, Historical 676 $a420/.9 701 $aLenker$b Ursula$01466435 712 12$aInternational Conference on English Historical Linguistics 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910782038003321 996 $aConnectives in the history of English$93848191 997 $aUNINA LEADER 02489nam0 2200493 i 450 001 VAN0114828 005 20220307034419.418 017 70$2N$a978-3-319-32562-0 100 $a20180213d2016 |0itac50 ba 101 $aeng 102 $aCH 105 $a|||| ||||| 200 1 $aGroup sequential and confirmatory adaptive designs in clinical trials$fGernot Wassmer, Werner Brannath 210 $a[Cham]$cSpringer$d2016 215 $aXVI, 301 p.$cill.$d24 cm 410 1$1001VAN0114829$12001 $aSpringer Series in Pharmaceutical Statistics$1210 $aBerlin [etc.]$cSpringer 500 1$3VAN0242414$aGroup sequential and confirmatory adaptive designs in clinical trials$91523374 606 $a92-XX$xBiology and other natural sciences [MSC 2020]$3VANC020839$2MF 606 $a62-XX$xStatistics [MSC 2020]$3VANC022998$2MF 606 $a62Kxx$xDesign of statistical experiments [MSC 2020]$3VANC023621$2MF 606 $a62K10$xStatistical block designs [MSC 2020]$3VANC023659$2MF 606 $a62P10$xApplications of statistics to biology and medical sciences; meta analysis [MSC 2020]$3VANC024649$2MF 606 $a92B15$xGeneral Biostatistics [MSC 2020]$3VANC026442$2MF 606 $a62H15$xHypothesis testing in multivariate analysis [MSC 2020]$3VANC030964$2MF 606 $a62N02$xEstimation in survival analysis and censored data [MSC 2020]$3VANC033692$2MF 606 $a62K05$xOptimal statistical designs [MSC 2020]$3VANC033803$2MF 606 $a62N03$xTesting in survival analysis and censored data [MSC 2020]$3VANC033860$2MF 610 $aAdaptive designs$9KW:K 610 $aClinical Trials$9KW:K 610 $aGroup sequential designs$9KW:K 610 $aMultiple hypotheses$9KW:K 610 $aSample Size$9KW:K 620 $aCH$dCham$3VANL001889 700 1$aWassmer$bGernot$3VANV088855$0755933 701 1$aBrannath$bWerner$3VANV088856$0755934 712 $aSpringer $3VANV108073$4650 801 $aIT$bSOL$c20240614$gRICA 856 4 $uhttp://dx.doi.org/10.1007/978-3-319-32562-0$zE-book ? Accesso al full-text attraverso riconoscimento IP di Ateneo, proxy e/o Shibboleth 899 $aBIBLIOTECA CENTRO DI SERVIZIO SBA$2VAN15 912 $fN 912 $aVAN0114828 950 $aBIBLIOTECA CENTRO DI SERVIZIO SBA$d15CONS SBA EBOOK 2288 $e15EB 2288 20180213 996 $aGroup sequential and confirmatory adaptive designs in clinical trials$91523374 997 $aUNICAMPANIA